Jerrold B. Grossman Ph.D., D.P.S.
Net Worth

Last updated:

What is Jerrold B. Grossman Ph.D., D.P.S. net worth?

The estimated net worth of Dr. Jerrold B. Grossman Ph.D., D.P.S. is at least $11,383,291 as of 29 Aug 2024. He owns shares worth $8,168,491 as insider, has earned $2,364,000 from insider trading and has received compensation worth at least $850,800 in ADMA Biologics, Inc..

What is the salary of Jerrold B. Grossman Ph.D., D.P.S.?

Dr. Jerrold B. Grossman Ph.D., D.P.S. salary is $70,900 per year as Co-Founder & Vice Chairman in ADMA Biologics, Inc..

How old is Jerrold B. Grossman Ph.D., D.P.S.?

Dr. Jerrold B. Grossman Ph.D., D.P.S. is 77 years old, born in 1948.

What stocks does Jerrold B. Grossman Ph.D., D.P.S. currently own?

As insider, Dr. Jerrold B. Grossman Ph.D., D.P.S. owns shares in one company:

Company Title Shares Price per share Total value
ADMA Biologics, Inc. (ADMA) Co-Founder & Vice Chairman 467,305 $17.48 $8,168,491

What does ADMA Biologics, Inc. do?

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA logo
ADMA
ADMA Biologics, Inc.
$17.48

Jerrold B. Grossman Ph.D., D.P.S. insider trading

ADMA Biologics, Inc.

Dr. Jerrold B. Grossman Ph.D., D.P.S. has made only one insider trade between 2013-2024, according to the Form 4 filled with the SEC.

As of 29 Aug 2024 he still owns at least 467,305 units of ADMA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 136,861 $6.81 $931,613
Option
Common Stock 118,861 $3.66 $435,031
Option
Common Stock 9,000 $5.96 $53,640
Option
Common Stock 9,000 $10.8 $97,200
Sale
Common Stock 136,861 $17.27 $2,364,000
Purchase
Common Stock 130,000 $3.71 $482,170
Purchase
Common Stock 100,000 $1 $100,000
Purchase
Common Stock 5,000 $2.22 $11,100
Purchase
Common Stock 5,300 $2.59 $13,727
Purchase
Common Stock 10,200 $2.89 $29,447
Purchase
Common Stock 45,714 $3.5 $159,999
Purchase
Common Stock 12,000 $4 $48,000
Purchase
Common Stock 52,302 $4.78 $250,004
Option
Common Stock 48,185 $2.68 $129,136
Option
Employee Stock Option (right to buy) 48,185 $2.68 $129,136
Purchase
Common Stock, $0.0001 par value per share 45,769 $6.5 $297,499
Purchase
Common Stock, $0.0001 par value per share 4,000 $8.48 $33,920
Purchase
Common Stock, $0.0001 par value per share 500 $9.01 $4,503
Purchase
Common Stock, $0.0001 par value per share 6,000 $9.16 $54,960
Purchase
Common Stock, $0.0001 par value per share 500 $8.01 $4,005
Purchase
Common Stock, $0.0001 par value per share 1,200 $8 $9,598
Purchase
Common Stock, $0.0001 par value per share 800 $9.5 $7,600
Purchase
Common Stock, $0.0001 par value per share 4,150 $7.3 $30,295
Purchase
Common Stock, $0.0001 par value per share 79,410 $8.5 $674,985

ADMA Biologics key executives

ADMA Biologics, Inc. executives and other stock owners filed with the SEC: